Skip to main content
Caplight Logo









EnlitenAI

EnlitenAI

Private
Tracy, CaliforniaHealthcare & Life Scienceshttps://enlitenai.com/

Last Round

Grant

Sep 4, 2025

Total Funding Raised

$155,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EnlitenAI is a health technology company that has developed an AI-driven, cloud-based SaaS platform for the management and treatment of neurological conditions, with an initial focus on epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Health IoT, Healthcare Analytics, Patient Engagement, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Government Contracts

AI Layer

Application

Keywords

clinical decision supportepilepsy managementSoftware as a Medical DeviceSaMDneurology softwaredigital therapeuticsremote patient monitoringmedical AIwearable data integrationpersonalized treatmentdrug titrationseizure managementdevice-agnostic platformhealth IoTdata monetization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnlitenAI Comparables

Compare EnlitenAI with similar companies based on industry and business-model similarity.

EnlitenAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eysz
79%
Rune Labs
78%
moveUP
78%

EnlitenAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 4, 2025
SeedMar 1, 2025
GrantOct 18, 2022

Key People

Founding team and executive leadership

Himanshu Misra

Chief Executive Officer, Co-founder

Founding Team

Sreeman Nanduri

CTO Product and technology Advisor

Executive Team

EnlitenAI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 31% MoM, reaching 2.4K.

  • Jan 21, 2026

    Monthly visitors increased 48% MoM.

EnlitenAI Filings

Explore SEC and related filing metadata, where available.

EnlitenAI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EnlitenAI's valuation, stock price, and market status.

Is EnlitenAI a public or private company?

EnlitenAI is a private company.

What is the current stock price of EnlitenAI?

EnlitenAI is a private company with no public stock price. No recent secondary market data is available.

How much is EnlitenAI worth (valuation)?

Valuation information for EnlitenAI is not publicly available.

Can I buy EnlitenAI stock?

EnlitenAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EnlitenAI's last funding round?

EnlitenAI's most recent funding round was Grant on September 4, 2025.

Who are the main investors in EnlitenAI?

Key investors in EnlitenAI include IIT Startups, Aurelia Ventures, Innosphere Ventures, City of Elk Grove, Colorado Office of Economic Development and International Trade.

Will EnlitenAI IPO soon?

No public IPO plans have been announced for EnlitenAI.

How can I track EnlitenAI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EnlitenAI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTracy, California
Employee Range5
Year Founded2020
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?